MMC vs STRO · P/E 22, rev $24.46B vs rev $62.0M
Marsh & McLennan Companies Inc (MMC) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Marsh & McLennan Companies Inc (MMC) is a insurance brokers company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported MMC revenue for 2024-12-31 was $24.46B. Net income was $4.12B. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
MMC currently screens at market cap $89.82B and trailing P/E 21.9. STRO currently screens at market cap $470.8M.
Not investment advice. Open the MMC and STRO stock pages for the full models.
Not investment advice.